Medisys Grows By Shrinking

Streamlining and cutting revenue-generating services and offerings can be a risky move for a company, but it's a move that Anna Walz, founder and CEO of Medisys Health Communications, had to make...

Get small to get big. (In other words, it's all about the niches)

Two years ago, Medisys Health Communications was in big trouble. The 12-year-old biotech-consulting firm hadn't won a significant contract in months. Revenue, which hit $5 million in 2008, was down to $1.4 million in 2010. It wasn't hard to see why: The sagging economy meant a lot fewer RFPs from major pharmaceutical firms—and a lot more competition from rivals, especially large ones that could offer a wider array of services...

Agencies to build momentum from 2011 growth

Two agencies – StrikeForce Communications and Medisys Health Communications– have entered 2012 with a year of growth behind them. While StrikeForce has announcedthe agency tripled its revenue in 2011, Medisys leaders have announced their own company has experienced 100 percent growth

Top 100 Inspiring People

Leading her company with innovative thinking and planning, Anna Walz staged a successful relaunch of Medisys in 2011 by radically downsizing the company.She eliminated more than three-quarters of it's revenue-generarting services

Best 50 women in business

Ana Walz, CEO of MedEvoke, a Medisys Health Communications LLC company located in High Bridge, N.J., has been named one of New Jersey’s 2013 Best 50 Women in Business. The award program, produced by NJBIZ, New Jersey’s premiere business news publication

 

Hot off the Press

February 26, 2014

Diversity Alliance for Science appoints Anna Walz, CEO for MedEvoke, to its Board of Directors MedEvoke, a leading medical communications company with unique expertise in driving organizationally aligned scientific narrative development for biopharmaceutical companies, today announced the selection of its CEO, Anna Walz, to the Board of Directors for Diversity Alliance for Science. Effective February 27, 2014, Walz will begin serving a two-year term as Board member. As the CEO of a female-led, minority-owned, certified diverse supplier, Walz has grown MedEvoke from a small enterprise to one that is perceived by numerous top-10 pharmaceutical companies as an essential strategic partner in narrative development for products at all stages of the life cycle.

Read more ...

The Challenge

How will you reconcile competing goals, objectives, languages, cultures and budgets across the many organizational functions and regional affiliates?

The Solution

Why Align?

Every day a launch is delayed can cost your company $8MM
Inefficient clinical trials that fail to reflect a clear scientific narrative cost the industry $4-6B annually

Get Aligned

DMC Firewall is a Joomla Security extension!